Ibrance:

Facts of Ibrance™ (palbociclib) Capsules 125mg ?

• Medicine Name: Ibrance™
• Generic Name: Palbociclib
• Approval Date: Feb 3, 2015
• Company Name: Pfizer Labs
• Available as (Form & Strength): Capsules: 125 mg, 100 mg, and 75 mg

What are the indications and usage?

IBRANCE ® is indicated in combination with letrozole for the treatment of postmenopausal women with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer as initial endocrine-based therapy for their metastatic disease.